Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MUSTANG BIO, INC. Director's Dealing 2017

Jun 7, 2017

35167_dirs_2017-06-07_99db5d47-fb66-40aa-8bbe-d48ef2e28882.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: MUSTANG BIO, INC. (NONE)
CIK: 0001680048
Period of Report: 2016-09-26

Reporting Person: Fortress Biotech, Inc. (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock, par value $0.0001 9000000 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Class A Preferred Stock, $0.0001 par value $ Common Stock (250000) Direct

Footnotes

F1: Each share of the Issuer's Class A Preferred Stock is convertible at any time at the option of the Reporting Person into one share of the Issuer's Common Stock and has no expiration date.